URELUMAB
UNII 230902QLLC

Substance Identification & Data

This profile provides standardized clinical and technical data for Urelumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 230902QLLC.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 934823-49-1 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
230902QLLC
CAS Registry Number
934823-49-1
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
URELUMAB
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
INN ID
9365
Sequential identifier assigned via the WHO International Nonproprietary Name program.
USAN ID
UU-01
Identifier assigned by the United States Adopted Names Council.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Urelumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

URELUMAB

Common Names & Synonyms

IMMUNOGLOBULIN G4, ANTI-(HUMAN RECEPTOR 4-1BB) (HUMAN .GAMMA.-CHAIN), DISULFIDE WITH HUMAN .KAPPA.-CHAIN, DIMER
URELUMAB [INN]
URELUMAB [USAN]
URELUMAB [WHO-DD]

Technical Codes

BMS-663513